Enhancing research capacities in infectious diseases: The GABRIEL network, a joint approach to major local health issues in developing countries

Clinical Epidemiology and Global Health

Volumn 1, Issue 1, 2013, Pages 40-43

  Komurian Pradel, Florence ^a   Grundmann, Nina ^a   Siqueira, Marilda M ^b   Chou, Monidarin ^c   Diallo, Souleymane ^d   Mbacham, Wilfred ^e   Paboriboune, Phimpha ^f   Russomando, Graciela ^g   Nymadawa, Pagbajab ^h   Sarkis, Dolla Karam ⁱ   Samison, Luc Hervé ^j   Wang, Jianwei ^k   Pape, Jean W ^l   Paranhos Baccalà, Gláucia ^a   Vernet, Guy ^a  

^a Emerging Pathogens Laboratory   (France)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Faculty of Pharmacy   (Cambodia)

^d Centre d Infectiologie Charles Mérieux Mali CICMMali   (Mali)

^e UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^f Ministry of Health of the Lao People's Democratic Republic   (Laos)

^g Instituto de Investigaciones en Ciencias de la Salud (IICS) of the National Univ of Asuncion   (Paraguay)

^h Mongolian Academy of Medical Sciences ^*  (Mongolia)

ⁱ SAINT JOSEPH UNIVERSITY   (Lebanon)

^j UNIVERSITY OF ANTANANARIVO   (Madagascar)

^k PEKING UNION MEDICAL COLLEGE   (China)

^l Centers Institute of Infectious Diseases and Reproductive Health   (Haïti)

more..

Author keywords

Developing countries; Network; Research capacities; Respiratory tract infections; Tuberculosis multidrug resistance

Indexed keywords

ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTERIUM DETECTION; DEVELOPING COUNTRY; DISEASE SURVEILLANCE; FINANCIAL MANAGEMENT; FUNDING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; INFECTION RISK; INTERNATIONAL COOPERATION; LOWEST INCOME GROUP; MEDICAL RESEARCH; MULTIDRUG RESISTANT TUBERCULOSIS; NOTE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; RESEARCH UTILIZATION GROUP;

EID: 84964255485     PISSN: None     EISSN: 22133984     Source Type: Journal    
DOI: 10.1016/j.cegh.2012.11.002     Document Type: Note

References (7)

1. World Health Organization The Global Burden of Diseases: 2004 Update 2008, http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf.
2. Bryce J., Boschi-Pinto C., Shibuya K., Black R.E. WHO estimates of the causes of death in children. Lancet 2005, 365(9465):1147-1152.
3. Burman L.A., Trollfors B., Andersson B., et al. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis 1991, 163(5):1087-1093.
4. Waterer G.W., Wunderink R.G. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 2001, 95(1):78-82.
5. Madhi S.A., Klugman K.P. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004, 10:811-813. Vaccine Trialist Group.
6. Whitney C.G., Harper S.A. Lower respiratory tract infections: prevention using vaccines. Infect Dis Clin North Am 2004, 18(4):899-917.
7. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010 global report on surveillance and response. WHO/HTM/TB/2010.3.